Cargando…
Current Molecular Combination Therapies Used for the Treatment of Breast Cancer
Breast cancer is the second leading cause of death for women worldwide. While monotherapy (single agent) treatments have been used for many years, they are not always effective, and many patients relapse after initial treatment. Moreover, in some patients the response to therapy becomes weaker, or r...
Autores principales: | Wang, Yiling, Minden, Audrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569555/ https://www.ncbi.nlm.nih.gov/pubmed/36232349 http://dx.doi.org/10.3390/ijms231911046 |
Ejemplares similares
-
The Use of Nanomedicine to Target Signaling by the PAK Kinases for Disease Treatment
por: Wang, Yiling, et al.
Publicado: (2021) -
The Pak4 Protein Kinase in Breast Cancer
por: Minden, Audrey
Publicado: (2012) -
PAK4–6 in cancer and neuronal development
por: Minden, Audrey
Publicado: (2012) -
Molecular targeted therapies for breast cancer treatment
por: Schlotter, Claus M, et al.
Publicado: (2008) -
Current Research Status of Metronomic Chemotherapy in Combination Treatment of Breast Cancer
por: Liu, Jiaxuan, et al.
Publicado: (2022)